Literature DB >> 11511034

Degradation of poly(D,L)lactide implants with or without addition of calciumphosphates in vivo.

W Heidemann1, S Jeschkeit, K Ruffieux, J H Fischer, M Wagner, G Krüger, E Wintermantel, K L Gerlach.   

Abstract

The study was aimed at examining the in vivo degradation of pure poly(D,L)lactide (PDLLA) or PDLLA with an admixture of calciumphosphates. One rod (20 x 3 x 2 mm) and one cube (3 x 2 x 2 mm) of pure PDLLA, PDLLA with tricalciumphosphate (PDLLA + TCP) or PDLLA with calciumhydrogenphosphate (PDLLA + CHP), respectively, were implanted into the dorsal muscles of 50 male Wistar Albino rats. After definite intervals (from 2nd to 72nd week), pH measurements were performed in the environment of the implants. Afterwards, the cubes with their surrounding tissues were excised for histological examinations, measurements of the outer dimensions and mechanical analyses of the explanted rods were performed. No drop of more than 0.1 pH units was detectable in the tissue surrounding any type of implants. No advantageous effect of the calciumphosphates could be proved. A mild foreign body reaction could be observed around PDLLA implants. After 72 weeks, pure PDLLA had been totally resorbed from the extracellular space, the degradation of calciumphosphate-enriched PDLLA was still in progress. A large amount of inflammations occurred in the tissues surrounding PDLLA with an admixture of slowly degrading TCP or CHP, leading to two abscesses and four fistulas at PDLLA + TCP, and two abscesses and three fistulas at PDLLA + CHP implantation site. Bending strength of pure PDLLA was constant up to the 4th week post-implantation and reduced to 60% of the initial value up to the 12th week. No traces of crystallinity could be observed during the degradation of PDLLA. As a conclusion of the study, complete resorption from the extracellular space and tissue tolerance of pure PDLLA is proved. An admixture of small calciumphosphate particles is not suitable to improve the biocompatibility of PDLLA but leads to a decrease in the mechanical characteristics.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511034     DOI: 10.1016/s0142-9612(00)00424-5

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  16 in total

1.  The degradation properties of co-continuous calcium phosphate polyester composites: insights with synchrotron micro-computer tomography.

Authors:  Lisa M Ehrenfried; David Farrar; Ruth E Cameron
Journal:  J R Soc Interface       Date:  2010-06-10       Impact factor: 4.118

2.  Letter to the editor: Fibroxanthoma: a complication of a biodegradable screw.

Authors:  Thomas W Bauer
Journal:  Clin Orthop Relat Res       Date:  2011-01       Impact factor: 4.176

Review 3.  [Biomaterials in orthopedics].

Authors:  S Vogt; T Tischer; F Blanke
Journal:  Orthopade       Date:  2015-08       Impact factor: 1.087

4.  Titanium dioxide (TiO(2)) nanoparticles filled poly(D,L lactid acid) (PDLLA) matrix composites for bone tissue engineering.

Authors:  L-C Gerhardt; G M R Jell; A R Boccaccini
Journal:  J Mater Sci Mater Med       Date:  2007-01-09       Impact factor: 3.896

5.  Increased Runx2 expression associated with enhanced Wnt signaling in PDLLA internal fixation for fracture treatment.

Authors:  Zhuoyan Ling; Lei Wu; Gaolong Shi; Li Chen; Qirong Dong
Journal:  Exp Ther Med       Date:  2017-03-10       Impact factor: 2.447

6.  [In vivo study of degradation of poly-(D,L-) lactide and poly-(L-lactide-co-glycolide) osteosynthesis material].

Authors:  W Heidemann; J H Fischer; J Koebke; C Bussmann; K L Gerlach
Journal:  Mund Kiefer Gesichtschir       Date:  2003-09-20

7.  Novel bioresorbable and bioactive composites based on bioactive glass and polylactide foams for bone tissue engineering.

Authors:  J A Roether; J E Gough; A R Boccaccini; L L Hench; V Maquet; R Jérôme
Journal:  J Mater Sci Mater Med       Date:  2002-12       Impact factor: 3.896

Review 8.  The natural and engineered 3D microenvironment as a regulatory cue during stem cell fate determination.

Authors:  Amanda W Lund; Bülent Yener; Jan P Stegemann; George E Plopper
Journal:  Tissue Eng Part B Rev       Date:  2009-09       Impact factor: 6.389

Review 9.  Calcium Orthophosphate-Containing Biocomposites and Hybrid Biomaterials for Biomedical Applications.

Authors:  Sergey V Dorozhkin
Journal:  J Funct Biomater       Date:  2015-08-07

10.  An Ultrasound Assisted Anchoring Technique (BoneWelding Technology) for Fixation of Implants to Bone - A Histological Pilot Study in Sheep.

Authors:  Jens D Langhoff; Jan M Kuemmerle; Joerg Mayer; Urs Weber; Milica Berra; Jessika M Mueller; Sabine B Kaestner; Katalin Zlinszky; Joerg A Auer; Brigitte von Rechenberg
Journal:  Open Orthop J       Date:  2009-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.